Francis M Cuss
CIK 1490216 · EVP & CSO · last filed 2025-12-05
Francis M Cuss is an EVP & CSO who has filed 42 SEC Form 4 insider transactions across 4 companies since 2011. The most recent filing, for MURAV, was dated Dec 5, 2025. Across all open-market trades the lifetime net is −$19.0M, making them a net seller over the disclosed history. Current disclosed insider exposure totals $19.8M across reported positions.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$19.81M
4
42
-$18.97M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MURAV | Director | — | — | — | $0 | 5 | 2025-12-05 |
| Rubius Therapeutics, Inc. (RUBY) Delisted | Director | 10,000 | $0.08 | $830 | $230.0K | 6 | 2022-05-13 |
| BMY | EVP & CSO | 346,769 | $57.13 | $19.81M | -$12.63M | 18 | 2017-03-14 |
| BRISTOL MYERS SQUIBB CO (BMYp) Delisted | SVP Research | 195,161 | — | — | -$6.57M | 13 | 2013-03-14 |
Recent Filings
42 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-12-05 | MURAV | Disp (D) | — | $0 | EDGAR |
| 2025-06-13 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2024-06-05 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2024-06-03 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2023-12-18 | MURAV | Grant (A) | — | $0 | EDGAR |
| 2022-05-13 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-05-13 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-05-26 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-05-28 | Rubius Therapeutics, Inc. (RUBY) Delisted | Grant (A) | — | $0 | EDGAR |
| 2018-07-23 | Rubius Therapeutics, Inc. (RUBY) Delisted | Buy (P) | +10,000 | $230.0K | EDGAR |